COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Also, Scripps does not provide COVID-19 tests for asymptomatic patients. See FAQs.

Developing a Trial-Ready Cohort of Parkinson Disease Patients

Trial ID:
IRB-21-7866
Melissa K. Houser, M.D.
This study does not involve treatment. The purpose is to obtain skin cells from people with Parkinson Disease to create dopamine producing nerve cells for use in potential future clinical trials. Study visits will take place at Scripps Clinic Torrey Pines and Scripps Clinic Carmel Valley. Participation in this study is expected to last about 12 weeks.

Inclusion Criteria

Patients must:
  • Be 50-70 years of age
  • Be diagnosed with Parkinson Disease
  • Have been diagnosed with Parkinson Disease for at least 4 years

Exclusion Criteria

Patients must not:
  • Have had prior brain surgery, including deep brain stimulation (DBS)
  • Have a history of significant cognitive impairment or dementia
  • Have a history of severe dyskinesia
  • Have history of stroke, poorly controlled cardiovascular disease, uncontrolled hypertension, or diabetes

Additional Info

  • Participation in this study does not guarantee eligibility to participate in future clinical trials or that any clinical trials will occur.

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org